As of 2024-12-12, the Relative Valuation of Theraclion SA (ALTHE.PA) is (1.47) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.40 EUR, the upside of Theraclion SA based on Relative Valuation is -465.8%.
The range of the Relative Valuation is (1.01) - (1.64) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 21.2x | 15.2x |
| Forward P/E multiples | 13.1x - 29.9x | 23.0x |
| Fair Price | (1.01) - (1.64) | (1.47) |
| Upside | -350.9% - -507.0% | -465.8% |
| Date | P/E |
| 2024-11-25 | -4.40 |
| 2024-11-22 | -4.74 |
| 2024-11-21 | -4.74 |
| 2024-11-20 | -4.40 |
| 2024-11-19 | -4.04 |
| 2024-11-18 | -4.41 |
| 2024-11-15 | -4.54 |
| 2024-11-14 | -4.54 |
| 2024-11-13 | -4.54 |
| 2024-11-12 | -4.62 |
| 2024-11-11 | -4.86 |
| 2024-11-08 | -4.85 |
| 2024-11-07 | -4.98 |
| 2024-11-06 | -4.92 |
| 2024-11-05 | -4.76 |
| 2024-11-04 | -4.79 |
| 2024-11-01 | -4.79 |
| 2024-10-31 | -4.88 |
| 2024-10-30 | -4.84 |
| 2024-10-29 | -4.89 |
| 2024-10-28 | -4.98 |
| 2024-10-25 | -4.89 |
| 2024-10-24 | -4.89 |
| 2024-10-23 | -4.90 |
| 2024-10-22 | -5.18 |
| 2024-10-21 | -5.15 |
| 2024-10-18 | -5.14 |
| 2024-10-17 | -5.08 |
| 2024-10-16 | -5.08 |
| 2024-10-15 | -5.14 |
| 2024-10-14 | -5.16 |
| 2024-10-11 | -5.18 |
| 2024-10-10 | -5.45 |
| 2024-10-09 | -5.40 |
| 2024-10-08 | -5.36 |
| 2024-10-07 | -5.43 |
| 2024-10-04 | -5.43 |
| 2024-10-03 | -5.30 |
| 2024-10-02 | -5.36 |
| 2024-10-01 | -5.61 |
| 2024-09-30 | -5.14 |
| 2024-09-27 | -5.30 |
| 2024-09-26 | -5.21 |
| 2024-09-25 | -5.30 |
| 2024-09-24 | -4.98 |
| 2024-09-23 | -4.97 |
| 2024-09-20 | -4.98 |
| 2024-09-19 | -5.14 |
| 2024-09-18 | -5.14 |
| 2024-09-17 | -5.18 |